PURPOSE: To evaluate RTVue spectral-domain optical coherence tomography (OCT) (Optovue Inc, Fremont, California, USA) reproducibility and to assess agreement with Stratus time-domain OCT (Carl Zeiss Meditec, Dublin, California, USA) measurements. DESIGN: Observational clinical study. METHODS: Scans were obtained from both eyes of all participants 3 times using the RTVue nerve head map 4-mm diameter protocol and once using Stratus OCT within the same session. RTVue reproducibility and agreement with Stratus OCT were evaluated for retinal nerve fiber layer (RNFL) and optic disc measurements. RESULTS: Thirty healthy participants (60 eyes) and 38 glaucoma patients (76 eyes) were included in the study. RTVue reproducibility was good in both healthy participants and patients. For average RNFL thickness, the intraclass correlation coefficients in healthy eyes and patient eyes were 0.97 whereas for rim area they were 0.97 and 0.96, respectively. The correlation between RTVue and Stratus measurements generally was good, especially for average RNFL thickness (healthy eyes and patient eyes, r(2) = 0.82 and 0.86, respectively) and rim volume (healthy eyes and patient eyes, r(2) = 0.78 and 0.76, respectively). Bland-Altman plots showed good agreement between the instruments, with better agreement for average RNFL thickness (95% limits of agreement in healthy eyes and patient eyes, -8.6 to 12 microm and -5.6 to -14.8 microm, respectively) than optic disc parameters. Cup-to-disc ratio 95% limits of agreement in healthy eyes and patient eyes were -0.3 to 0.4 and -0.2 to 0.3, respectively. Optic disc measurements with RTVue were smaller than those with Stratus OCT (eg, disc area was on average 0.4 mm(2) smaller and rim area was 0.3 mm(2) smaller with RTVue). CONCLUSIONS: Reproducibility of RTVue RNFL and optic disc measurements was excellent in both groups. The level of agreement between RTVue and Stratus measurements suggests that RTVue has the potential to detect glaucomatous structural changes.
PURPOSE: To evaluate RTVue spectral-domain optical coherence tomography (OCT) (Optovue Inc, Fremont, California, USA) reproducibility and to assess agreement with Stratus time-domain OCT (Carl Zeiss Meditec, Dublin, California, USA) measurements. DESIGN: Observational clinical study. METHODS: Scans were obtained from both eyes of all participants 3 times using the RTVue nerve head map 4-mm diameter protocol and once using Stratus OCT within the same session. RTVue reproducibility and agreement with Stratus OCT were evaluated for retinal nerve fiber layer (RNFL) and optic disc measurements. RESULTS: Thirty healthy participants (60 eyes) and 38 glaucomapatients (76 eyes) were included in the study. RTVue reproducibility was good in both healthy participants and patients. For average RNFL thickness, the intraclass correlation coefficients in healthy eyes and patient eyes were 0.97 whereas for rim area they were 0.97 and 0.96, respectively. The correlation between RTVue and Stratus measurements generally was good, especially for average RNFL thickness (healthy eyes and patient eyes, r(2) = 0.82 and 0.86, respectively) and rim volume (healthy eyes and patient eyes, r(2) = 0.78 and 0.76, respectively). Bland-Altman plots showed good agreement between the instruments, with better agreement for average RNFL thickness (95% limits of agreement in healthy eyes and patient eyes, -8.6 to 12 microm and -5.6 to -14.8 microm, respectively) than optic disc parameters. Cup-to-disc ratio 95% limits of agreement in healthy eyes and patient eyes were -0.3 to 0.4 and -0.2 to 0.3, respectively. Optic disc measurements with RTVue were smaller than those with Stratus OCT (eg, disc area was on average 0.4 mm(2) smaller and rim area was 0.3 mm(2) smaller with RTVue). CONCLUSIONS: Reproducibility of RTVue RNFL and optic disc measurements was excellent in both groups. The level of agreement between RTVue and Stratus measurements suggests that RTVue has the potential to detect glaucomatous structural changes.
Authors: Maciej Wojtkowski; Rainer Leitgeb; Andrzej Kowalczyk; Tomasz Bajraszewski; Adolf F Fercher Journal: J Biomed Opt Date: 2002-07 Impact factor: 3.170
Authors: Teresa C Chen; Barry Cense; Mark C Pierce; Nader Nassif; B Hyle Park; Seok H Yun; Brian R White; Brett E Bouma; Guillermo J Tearney; Johannes F de Boer Journal: Arch Ophthalmol Date: 2005-12
Authors: Mirjam E J van Velthoven; Dirk J Faber; Frank D Verbraak; Ton G van Leeuwen; Marc D de Smet Journal: Prog Retin Eye Res Date: 2006-12-08 Impact factor: 21.198
Authors: Carol Yim Lui Cheung; Christopher Kai Shun Leung; Dusheung Lin; Chi-Pui Pang; Dennis Shun Chiu Lam Journal: Ophthalmology Date: 2008-02-21 Impact factor: 12.079
Authors: J G Fujimoto; B Bouma; G J Tearney; S A Boppart; C Pitris; J F Southern; M E Brezinski Journal: Ann N Y Acad Sci Date: 1998-02-09 Impact factor: 5.691
Authors: Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Roberto M Vessani; Remo Susanna; Robert N Weinreb Journal: Am J Ophthalmol Date: 2005-01 Impact factor: 5.258
Authors: Donald L Budenz; Robert T Chang; Xiangrun Huang; Robert W Knighton; James M Tielsch Journal: Invest Ophthalmol Vis Sci Date: 2005-07 Impact factor: 4.799
Authors: Kyung Rim Sung; Jong S Kim; Gadi Wollstein; Lindsey Folio; Michael S Kook; Joel S Schuman Journal: Br J Ophthalmol Date: 2010-10-28 Impact factor: 4.638
Authors: Nancy M Buchser; Gadi Wollstein; Hiroshi Ishikawa; Richard A Bilonick; Yun Ling; Lindsey S Folio; Larry Kagemann; Robert J Noecker; Eiyass Albeiruti; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2012-06-20 Impact factor: 4.799
Authors: Madhusudhanan Balasubramanian; Christopher Bowd; Gianmarco Vizzeri; Robert N Weinreb; Linda M Zangwill Journal: Opt Express Date: 2009-03-02 Impact factor: 3.894